These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33933458)

  • 1. Comparative analysis of the physicochemical, toxicokinetic, and toxicological properties of ether-PFAS.
    Rice PA; Cooper J; Koh-Fallet SE; Kabadi SV
    Toxicol Appl Pharmacol; 2021 Jul; 422():115531. PubMed ID: 33933458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.
    Pizzurro DM; Seeley M; Kerper LE; Beck BD
    Regul Toxicol Pharmacol; 2019 Aug; 106():239-250. PubMed ID: 31078680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.
    Brase RA; Mullin EJ; Spink DC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of sources, multimedia distribution and health risks of novel fluorinated alternatives.
    Wang Y; Chang W; Wang L; Zhang Y; Zhang Y; Wang M; Wang Y; Li P
    Ecotoxicol Environ Saf; 2019 Oct; 182():109402. PubMed ID: 31280095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvent Suitability for HFPO-DA ("GenX" Parent Acid) in Toxicological Studies.
    Liberatore HK; Jackson SR; Strynar MJ; McCord JP
    Environ Sci Technol Lett; 2020 May; 7(7):477-481. PubMed ID: 32944590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.
    Smeltz M; Wambaugh JF; Wetmore BA
    Chem Res Toxicol; 2023 Jun; 36(6):870-881. PubMed ID: 37184865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluoroalkyl acids and related chemistries--toxicokinetics and modes of action.
    Andersen ME; Butenhoff JL; Chang SC; Farrar DG; Kennedy GL; Lau C; Olsen GW; Seed J; Wallace KB
    Toxicol Sci; 2008 Mar; 102(1):3-14. PubMed ID: 18003598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant uptake and soil fractionation of five ether-PFAS in plant-soil systems.
    Zhang W; Cao H; Liang Y
    Sci Total Environ; 2021 Jun; 771():144805. PubMed ID: 33529820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of structure-cytotoxicity in vitro relationship (SAR) for perfluorinated carboxylic acids.
    Kleszczyński K; Gardzielewski P; Mulkiewicz E; Stepnowski P; Składanowski AC
    Toxicol In Vitro; 2007 Sep; 21(6):1206-11. PubMed ID: 17572060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Chemical Category-Based Prioritization Approach for Selecting 75 Per- and Polyfluoroalkyl Substances (PFAS) for Tiered Toxicity and Toxicokinetic Testing.
    Patlewicz G; Richard AM; Williams AJ; Grulke CM; Sams R; Lambert J; Noyes PD; DeVito MJ; Hines RN; Strynar M; Guiseppi-Elie A; Thomas RS
    Environ Health Perspect; 2019 Jan; 127(1):14501. PubMed ID: 30632786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid Disrupting Effects of Old and New Generation PFAS.
    Coperchini F; Croce L; Ricci G; Magri F; Rotondi M; Imbriani M; Chiovato L
    Front Endocrinol (Lausanne); 2020; 11():612320. PubMed ID: 33542707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic Biotransformation and Defluorination of Fluoroalkylether Substances (ether PFAS): Substrate Specificity, Pathways, and Applications.
    Jin B; Zhu Y; Zhao W; Liu Z; Che S; Chen K; Lin YH; Liu J; Men Y
    Environ Sci Technol Lett; 2023 Sep; 10(9):755-761. PubMed ID: 37719205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected physicochemical aspects of poly- and perfluoroalkylated substances relevant to performance, environment and sustainability-part one.
    Krafft MP; Riess JG
    Chemosphere; 2015 Jun; 129():4-19. PubMed ID: 25245564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical review of the application of polymer of low concern regulatory criteria to fluoropolymers II: Fluoroplastics and fluoroelastomers.
    Korzeniowski SH; Buck RC; Newkold RM; Kassmi AE; Laganis E; Matsuoka Y; Dinelli B; Beauchet S; Adamsky F; Weilandt K; Soni VK; Kapoor D; Gunasekar P; Malvasi M; Brinati G; Musio S
    Integr Environ Assess Manag; 2023 Mar; 19(2):326-354. PubMed ID: 35678199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Fate of Cl-PFPECAs: Predicting the Formation of PFAS Transformation Products in New Jersey Soils.
    Evich MG; Davis M; Weber EJ; Tebes-Stevens C; Acrey B; Henderson WM; Goodrow S; Bergman E; Washington JW
    Environ Sci Technol; 2022 Jun; 56(12):7779-7788. PubMed ID: 35617513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in silico modeling of perfluoroalkyl substances mixture toxicity in an amphibian fibroblast cell line.
    Hoover G; Kar S; Guffey S; Leszczynski J; Sepúlveda MS
    Chemosphere; 2019 Oct; 233():25-33. PubMed ID: 31163305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PFAS-Tox Database: A systematic evidence map of health studies on 29 per- and polyfluoroalkyl substances.
    Pelch KE; Reade A; Kwiatkowski CF; Merced-Nieves FM; Cavalier H; Schultz K; Wolffe T; Varshavsky J
    Environ Int; 2022 Sep; 167():107408. PubMed ID: 35908389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a multiple endpoint bacterial reporter assay to evaluate toxicological relevant endpoints of perfluorinated compounds with different functional groups and varying chain length.
    Nobels I; Dardenne F; De Coen W; Blust R
    Toxicol In Vitro; 2010 Sep; 24(6):1768-74. PubMed ID: 20619337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats.
    Conley JM; Lambright CS; Evans N; Strynar MJ; McCord J; McIntyre BS; Travlos GS; Cardon MC; Medlock-Kakaley E; Hartig PC; Wilson VS; Gray LE
    Environ Health Perspect; 2019 Mar; 127(3):37008. PubMed ID: 30920876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Response, Dosimetric, and Metabolic Evaluations of Replacement PFAS Perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic) Acid (HFPO-TeA).
    Renyer A; Ravindra K; Wetmore BA; Ford JL; DeVito M; Hughes MF; Wehmas LC; MacMillan DK
    Toxics; 2023 Nov; 11(12):. PubMed ID: 38133352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.